Hydrogenated rapamycin derivatives
US5023262A · kind A · utility
153Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 1990 |
| Grant date | Jun 11, 1991 |
| Priority date | — |
| Expiry date | Aug 14, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/01
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A derivative of rapamycin where one, two, or three of the double bonds at the 1-,3-, or 5-positions of rapamycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.